By Andy Gordon One small startup is stepping up in the fight against COVID-19.
You may have never heard of 20/20 GeneSystems. But members of our First Stage Investor research service have. We recommended they invest in 20/20 back in 2017.
And now 20/20 is doing something we could not have predicted in 2017. This dynamic startup is gearing up to provide COVID-19 tests.
The company’s main business (and why we recommended you invest in it in the first place) is layering artificial intelligence over the top of blood tests to help detect cancer in its earliest stages.
An increasing number of people have used its tests …read more
